Updated:
Ascenta Capital
Ascenta Capital is a biotech venture capital firm focused on drug development. It helps innovative companies grow from their scientific foundations to advance...
Overview
Ascenta Capital is a biotech venture capital firm focused on drug development. It helps innovative companies grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. The firm makes concentrated investments and works in collaboration to support management teams with strategic and operational experience.
General information
Firm type
Private Equity
Year founded
2023
Location
Region
North America
Country
United States
City
Wilmington
Corporate office
Wilmington, United States
Principals
Evan Rachlin
MD — Co-Founder and Managing Partner
Lorence Kim
MD — Co-Founder and Advisory Partner
Paul Deutsch
MD / PhD — Advisory Partner
Michael Rosenblatt
MD — Advisory Partner
Jeff Chodakewitz
MD — Advisory Partner
Daniel Bloomfield
MD — Advisory Partner
John Gutierrez
MD — Principal
Leighanne Oh
MS — Vice President
Sector focus
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: